September 9, 2019 Comments Off on Valuation of Pharma Companies: 5 Key Considerations Posted in: Insights Valuing pharma companies isn’t the same as valuing non-pharma companies, for several reasons. Traditional business considerations are compounded by patent law and FDA approval processes when evaluating the investment potential of…
The post Valuation of…
August 19, 2019 Comments Off on Opportunities for Generic Drug Development Posted in: Insights Amid public outcry over rising costs of brand-name drugs, the prices of generic medicines have been falling, raising fears about the sustainability and profitability of major generics companies. But some…
The post Opportunities for Generic Drug Develop…
